Search

Search Results

• Possibilities of pharmaceutical care in orthopedic practice

  35-47

  Zoltán Karácsonyi

  Tamás Erdei

  Views:

  112

  Clinical pharmacy developed at the end of the 20th century in the United States of America, the undisclosed purpose of which is to expand the role of the pharmacist profession and to optimize patient-specific drug therapy. This change in attitude gave rise to the definition of pharmaceutical care, which gained ground both in the clinic and in public drug supply. While the effects of pharmaceutical care on the health care system can be better examined in the case of public drug supply chains with a larger number of patients, the role of care provided by clinical pharmacists in institutions providing orthopedic care has been little investigated, even though the available studies have yielded positive results regarding the quality and cost-effectiveness of health care.

• Economic benefits of pharmaceutical care for elderly patients with polypharmacy

  Zoltán Karácsonyi

  Tamás Erdei

  Gábor Viczján

  Ignác Óvári

  Views:

  198

  The danger of polypharmacy (polypragmasia) lies in the fact that it usually affects older people who suffer from several chronic diseases and who are also less likely to medication adherence. For this reason, it is important to follow the drug therapy of these patients in the pharmacies, where feedback to general practitioners and specialists can take place in the event of a problem. For this reason, the development of pharmaceutical care is crucial. In the case of polypharmacy patients, inadequate drug therapy greatly increases the development of adverse drug effects and thus may increase mortality and morbidity indicators. Knowing the facts, it can be said that although pharmaceutical care involves additional costs, the adverse drug effects filtered out by it mean reduction in expenses.